NICLOSAMIDE-EXFOLIATED ANIONIC CLAY NANOHYBRID REPURPOSED AS AN ANTIVIRAL DRUG FOR TACKLING COVID-19; ORAL FORMULATION WITH TWEEN 60/EUDRAGIT S100

The ongoing pandemic, COVID-19 (SARS-CoV-2), has afflicted millions of people around the world, necessitating that the scientific community work, diligently and promptly, on suitable medicaments. Although vaccination programs have been run globally, the new variants of COVID-19 make it difficult to...

Descripción completa

Detalles Bibliográficos
Autores principales: Rejinold, N. Sanoj, Piao, Huiyan, Choi, Goeun, Jin, Geun-Woo, Choy, Jin-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584645/
https://www.ncbi.nlm.nih.gov/pubmed/34785820
http://dx.doi.org/10.1007/s42860-021-00153-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584645/
https://www.ncbi.nlm.nih.gov/pubmed/34785820
http://dx.doi.org/10.1007/s42860-021-00153-6

Ejemplares similares